Transplanted dopaminergic neurons develop PD pathologic changes: a second case report
- PMID: 19006193
- DOI: 10.1002/mds.22369
Transplanted dopaminergic neurons develop PD pathologic changes: a second case report
Abstract
This report describes pathological changes within the grafted neurons of another patient with Parkinson's disease (PD) who died 14 years posttransplantation. Although numerous healthy appearing grafted neurons were present at this long-term time point, some displayed Lewy bodies as evidenced by alpha-synuclein, ubiquitin, and thioflavin-S staining. Additionally, there was a general loss of dopamine transporter-immunoreactivity in grafted neurons. Some grafted cell displayed a loss of tyrosine hydroxylase. These data support the emerging concept that PD-like pathology is seen in young grafted neurons when they survive long term.
(c) 2008 Movement Disorder Society.
Similar articles
-
Age-associated increases of alpha-synuclein in monkeys and humans are associated with nigrostriatal dopamine depletion: Is this the target for Parkinson's disease?Neurobiol Dis. 2007 Jan;25(1):134-49. doi: 10.1016/j.nbd.2006.08.021. Epub 2006 Oct 18. Neurobiol Dis. 2007. PMID: 17055279
-
Inverse relationship between the contents of neuromelanin pigment and the vesicular monoamine transporter-2: human midbrain dopamine neurons.J Comp Neurol. 2004 May 17;473(1):97-106. doi: 10.1002/cne.20098. J Comp Neurol. 2004. PMID: 15067721
-
The role of Nurr1 in the development of dopaminergic neurons and Parkinson's disease.Prog Neurobiol. 2005 Sep-Oct;77(1-2):128-38. doi: 10.1016/j.pneurobio.2005.09.001. Epub 2005 Oct 21. Prog Neurobiol. 2005. PMID: 16243425 Review.
-
Partial recovery of dopaminergic pathway after graft of adult mesenchymal stem cells in a rat model of Parkinson's disease.Neurochem Int. 2008 Jun;52(7):1332-42. doi: 10.1016/j.neuint.2008.02.003. Epub 2008 Mar 10. Neurochem Int. 2008. PMID: 18372079
-
Neuronal cell replacement in Parkinson's disease.J Intern Med. 2009 Oct;266(4):358-71. doi: 10.1111/j.1365-2796.2009.02155.x. J Intern Med. 2009. PMID: 19765180 Review.
Cited by
-
A review of proposed mechanisms for neurodegenerative disease.Front Aging Neurosci. 2024 Oct 8;16:1370580. doi: 10.3389/fnagi.2024.1370580. eCollection 2024. Front Aging Neurosci. 2024. PMID: 39439710 Free PMC article. Review.
-
Role of Lipids in the Pathogenesis of Parkinson's Disease.Int J Mol Sci. 2024 Aug 16;25(16):8935. doi: 10.3390/ijms25168935. Int J Mol Sci. 2024. PMID: 39201619 Free PMC article. Review.
-
Gut-Brain Axis in Focus: Polyphenols, Microbiota, and Their Influence on α-Synuclein in Parkinson's Disease.Nutrients. 2024 Jun 27;16(13):2041. doi: 10.3390/nu16132041. Nutrients. 2024. PMID: 38999791 Free PMC article. Review.
-
Sensitive detection of pathological seeds of α-synuclein, tau and prion protein on solid surfaces.PLoS Pathog. 2024 Apr 19;20(4):e1012175. doi: 10.1371/journal.ppat.1012175. eCollection 2024 Apr. PLoS Pathog. 2024. PMID: 38640117 Free PMC article.
-
Cell-to-cell transmitted alpha-synuclein recapitulates experimental Parkinson's disease.NPJ Parkinsons Dis. 2024 Jan 6;10(1):10. doi: 10.1038/s41531-023-00618-6. NPJ Parkinsons Dis. 2024. PMID: 38184623 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
